Editorial Policy and Review Status

WomenRx.com publishes educational health information about GLP-1 medications, hormone therapy, peptide medicine, labs, safety, access, and treatment logistics. Educational content does not diagnose, prescribe, or replace care from a licensed clinician.

Current review status

The generated article archive is undergoing source, attribution, date, and credential verification. Archive articles are excluded from the XML sitemap and marked noindex until a documented reviewer approves them. A displayed archive date is not a claim of clinical review.

Sources

We prioritize FDA labels, PubMed-indexed clinical trials, major society guidelines, prescribing information, clinical trial registries, and government or academic sources. Commercial sources may be used for pricing or access context, but not as the basis for medical claims.

Freshness

Published core pages are checked when major labels, guidelines, safety communications, or pivotal trials change the clinical interpretation. High-risk medication and safety topics receive priority. An archive page returns to the indexable set only after its review record is complete.

Conflicts and Commercial Separation

Editorial content is educational. It does not guarantee prescription approval, medical eligibility, insurance coverage, or dispensing. Commercial product pages and editorial medical articles are treated as separate surfaces with different review expectations.

Corrections

If an error is identified, WomenRx.com corrects the page, updates the modified date when the correction is material, and prioritizes safety-related corrections first. Readers can report issues at support@womenrx.com.